Immunoglobulin G,anti-(human carcinoembryonic antigen) (huma(219649-07-7)

ChemicalBook Optimization Suppliers
名前: Shanghai YuanYe Biotechnology Co., Ltd.  
電話番号: 021-61312847; 18021002903
電子メール: 3008007409@qq.com
名前: ShangHai Biochempartner Co.,Ltd  
電話番号: 177-54423994 17754423994
電子メール: 2853530910@QQ.com
名前: TargetMol Chemicals Inc.  
電話番号: +1-781-999-5354; +17819995354
電子メール: marketing@targetmol.com
名前: Wuhan Chemstan Biotechnology Co., Ltd.  
電話番号: 027-65317797 15926423062
電子メール: 422450190@qq.com
名前: TargetMol Chemicals Inc.  
電話番号: 4008200310
電子メール: marketing@tsbiochem.com
Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer 製品概要
化学名:
英語化学名:Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer
别名:Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer;Labetuzumab;Research Grade Labetuzumab(DHC21001);IMMU-14|||hMN-14|||IMMU-100;Research Grade Labetuzumab;Labetuzumab (anti-CEACAM5)
CAS番号:219649-07-7
分子式:
分子量:0
EINECS:
カテゴリ情報:
Mol File:Mol File
Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer
Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer 物理性質
外見 Liquid
Colorless to light yellow
安全性情報
MSDS Information
Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer Usage And Synthesis
使用Treatment of colorectal cancer (humanized monoclonal antibody hMN-14 targeting CEA- positive cancers).
brand nameCEA-CIDE (Immunomedics).
in vivo

Labetuzumab (0.5 mg/rat; i.v.; single) inhibits tumor growth in vivo[1].

Animal Model:Female nu/nu mice (6 to 8-week-old; inject TT cells)[1].
Dosage:0.5 mg/rat
Administration:Intravenous injection; single (1 day post-tumor cell injection)
Result:Significantly delaied growth of tumor, and led to 64%-70% inhibition of tumor size between days 32 and 60.
Tags:219649-07-7